These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA. Mitra AP IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310 [No Abstract] [Full Text] [Related]
27. 27th Annual JPMorgan Healthcare Conference--BioCryst and Emergent Biosolutions. Croasdell G; Gale S IDrugs; 2009 Mar; 12(3):149-51. PubMed ID: 19333891 [No Abstract] [Full Text] [Related]
28. [A symphony for the camptothecins]. Lansiaux A; Bailly C Bull Cancer; 2003 Mar; 90(3):239-45. PubMed ID: 12801826 [TBL] [Abstract][Full Text] [Related]
29. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs. Chen AY; Chou R; Shih SJ; Lau D; Gandara D Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660 [TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors: from bench to clinic. Paris M; Porcelloni M; Binaschi M; Fattori D J Med Chem; 2008 Mar; 51(6):1505-29. PubMed ID: 18247554 [No Abstract] [Full Text] [Related]
31. Emerging DNA topisomerase inhibitors as anticancer drugs. Denny WA Expert Opin Emerg Drugs; 2004 May; 9(1):105-33. PubMed ID: 15155139 [TBL] [Abstract][Full Text] [Related]
37. Recent advances in topoisomerase I-targeting agents, camptothecin analogues. Kim DK; Lee N Mini Rev Med Chem; 2002 Dec; 2(6):611-9. PubMed ID: 12370044 [TBL] [Abstract][Full Text] [Related]
38. Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction. Manikumar G; Wadkins RM; Bearss D; Von Hoff DD; Wani MC; Wall ME Bioorg Med Chem Lett; 2004 Nov; 14(21):5377-81. PubMed ID: 15454230 [TBL] [Abstract][Full Text] [Related]
39. New anticancer agents. Weiss GR; Burris 3rd HA; Eckardt JR; Eckhardt SG; Fields SM; O'Rourke T; Rodriguez GI; Rothenberg ML; Valley AJ Cancer Chemother Biol Response Modif; 1996; 16():132-67. PubMed ID: 8639381 [No Abstract] [Full Text] [Related]
40. New drugs target hypoxia response in tumors. Garber K J Natl Cancer Inst; 2005 Aug; 97(15):1112-4. PubMed ID: 16077066 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]